Secondary Logo

Journal Logo

Articles by Siegfried Kasper

The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment – a European multicentre study

Höfer, Peter; Schosser, Alexandra; Calati, Raffaella; More

International Clinical Psychopharmacology. 31(1):1-7, January 2016.

Extended-release quetiapine fumarate (quetiapine XR) versus risperidone in the treatment of depressive symptoms in patients with schizoaffective disorder or schizophrenia: a randomized, open-label, parallel-group, flexible-dose study

Di Fiorino, Mario; Montagnani, Gino; Trespi, Graziella; More

International Clinical Psychopharmacology. 29(3):166-176, May 2014.

Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder

Kocabas, Neslihan Aygun; Antonijevic, Irina; Faghel, Carole; More

International Clinical Psychopharmacology. 26(1):1-10, January 2011.

Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder: a randomized, double-blind, placebo controlled trial

Kasper, Siegfried; Gastpar, Markus; Müller, Walter E.; More

International Clinical Psychopharmacology. 25(5):277-287, September 2010.

Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study

Mendlewicz, Julien; Massat, Isabelle; Linotte, Sylvie; More

International Clinical Psychopharmacology. 25(5):297-301, September 2010.

Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression

Kasper, Siegfried; Gastpar, Markus; Möller, Hans-Juergen; More

International Clinical Psychopharmacology. 25(4):204-213, July 2010.

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case–control association study

Kocabas, Neslihan Aygun; Faghel, Carole; Barreto, Mara; More

International Clinical Psychopharmacology. 25(4):218-227, July 2010.

5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder

Noro, Magali; Antonijevic, Irina; Forray, Carlos; More

International Clinical Psychopharmacology. 25(4):228-231, July 2010.

Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients

Serretti, Alessandro; Calati, Raffaella; Massat, Isabelle; More

International Clinical Psychopharmacology. 24(5):250-256, September 2009.

Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram

Kasper, Siegfried; Sacher, Julia; Klein, Nikolas; More

International Clinical Psychopharmacology. 24(3):119-125, May 2009.

Which antidepressants have demonstrated superior efficacy? A review of the evidence

Montgomery, Stuart A.; Baldwin, David S.; Blier, Pierre; More

International Clinical Psychopharmacology. 22(6):323-329, November 2007.

Show: